AKCEA-APOCIII-LRx

Ionis, Akcea boosted by a positive PhII for their Novartis castoff cardio drug — and they plan to push ahead into pivotals
Endpoints
Wed, 01/22/20 - 11:00 am
Novartis
Akcea
Medco
AKCEA-APOCIII-LRx
antisense